Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
Adamantios Mamais, Jillian H. Kluss, Luis Bonet‐Ponce, et al.
PLoS Biology (2021) Vol. 19, Iss. 12, pp. e3001480-e3001480
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential
Xv-shen Ding, Li Gao, Han Zheng, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102077-102077
Closed Access | Times Cited: 67
Perspective on the current state of the LRRK2 field
Jean‐Marc Taymans, Matt Fell, Tim Greenamyre, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 66
Metabolic reprogramming and polarization of microglia in Parkinson’s disease: Role of inflammasome and iron
Haiyang Yu, Qing Chang, Tong Sun, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102032-102032
Closed Access | Times Cited: 56
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Leilei Chen, Qingqing Shen, Yingjuan Liu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
LRRK2 recruitment, activity, and function in organelles
Luis Bonet‐Ponce, Mark Cookson
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 6871-6890
Open Access | Times Cited: 60
Brain Iron Metabolism, Redox Balance and Neurological Diseases
Guofen Gao, Linhao You, J. J. Zhang, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1289-1289
Open Access | Times Cited: 36
LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
Narayana Yadavalli, Shawn M. Ferguson
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 31
Open Access | Times Cited: 32
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 27
LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease
Zijian Zheng, Shushan Zhang, Xinjie Liu, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Open Access | Times Cited: 10
Impact of Type II LRRK2 inhibitors on signaling and mitophagy
Anna Tasegian, François Singh, Ian G. Ganley, et al.
Biochemical Journal (2021) Vol. 478, Iss. 19, pp. 3555-3573
Open Access | Times Cited: 51
Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis
Suzanne C. Edavettal, Pilar Cejudo-Martı́n, B. Dasgupta, et al.
Med (2022) Vol. 3, Iss. 12, pp. 860-882.e15
Open Access | Times Cited: 37
Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
Anindita Bose, Gregory A. Petsko, Lorenz Studer
Trends in Neurosciences (2022) Vol. 45, Iss. 8, pp. 608-620
Open Access | Times Cited: 33
Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment
Jillian H. Kluss, Luis Bonet‐Ponce, Patrick A. Lewis, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105769-105769
Open Access | Times Cited: 31
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors
Dan Dou, Jayne Aiken, Erika L.F. Holzbaur
The Journal of Cell Biology (2024) Vol. 223, Iss. 6
Open Access | Times Cited: 7
LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting
Yulan Xiong, Jianzhong Yu
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 982-996
Closed Access | Times Cited: 7
The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons
Adamantios Mamais, Anwesha Sanyal, Austin Fajfer, et al.
Stem Cell Reports (2024) Vol. 19, Iss. 2, pp. 163-173
Open Access | Times Cited: 6
Visualizing alpha‐synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo
Nadja Straumann, Benjamin F. Combes, Xosé Luis Dean Ben, et al.
Brain Pathology (2024) Vol. 34, Iss. 6
Open Access | Times Cited: 6
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder
Ana Kolicheski, Pierpaolo Turcano, Nicole Tamvaka, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 8, pp. 2353-2367
Open Access | Times Cited: 27
LRRK2 as a target for modulating immune system responses
Isabella Russo, Luigi Bubacco, Elisa Greggio
Neurobiology of Disease (2022) Vol. 169, pp. 105724-105724
Open Access | Times Cited: 24
The Mechanism and Function of Glia in Parkinson's Disease
Xinguo Zhang, Ruiqi Zhang, Maher Un Nisa Awan, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 23
LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF‐β1 in Parkinson's Disease
Longping Yao, Fengfei Lu, Sumeyye Koc, et al.
Advanced Science (2023) Vol. 10, Iss. 30
Open Access | Times Cited: 14
The emerging role of LRRK2 in tauopathies
Susanne Herbst, Patrick A. Lewis, Huw R. Morris
Clinical Science (2022) Vol. 136, Iss. 13, pp. 1071-1079
Open Access | Times Cited: 19
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
Noah Lubben, Julia K. Brynildsen, Connor M. Webb, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cells
Gerone A. Gonzales, Song Huang, Liam Wilkinson, et al.
Science Immunology (2024) Vol. 9, Iss. 101
Open Access | Times Cited: 4
LRRK2 protects immune cells against erastin-induced ferroptosis
Asmaa Oun, Ahmed Soliman, Marina Trombetta-Lima, et al.
Neurobiology of Disease (2022) Vol. 175, pp. 105917-105917
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top